LabCorp Announces New Leadership Roles for Its Two Business Segments and Selects New Chief Human Resources Officer

    John Ratliff , current CEO of Covance, to become CEO of LabCorp Diagnostics   Dr. Paul Kirchgraber , current senior vice president and head of Covance’s clinical trial testing solutions, to become CEO of Covance   Both business segment CEO roles are effective Nov. 1 when Adam H.

LabCorp Publishes Largest Study to Date on Prenatal Cell-Free DNA Screenings in Multifetal Pregnancies

Study of nearly 30,000 cases finds that non-invasive cfDNA screening for fetal aneuploidy in pregnancies with twins, triplets, and higher-order multiples meets or exceeds performance of singleton pregnancy screening   BURLINGTON, N.C. --(BUSINESS WIRE)--Sep.

LabCorp to Announce Third Quarter Financial Results on October 24, 2019

  BURLINGTON, N.C. --(BUSINESS WIRE)--Sep. 24, 2019-- LabCorp® (NYSE: LH) will release its third quarter of 2019 financial results before the market opens on Thursday, Oct. 24, 2019 , followed by a conference call and webcast beginning at 9:00 a.m. EDT to discuss the results.

Identification of two novel deletions with breakpoints located in Exon 11 in the BRCA2 gene